Pages that link to "Q46521013"

The following pages link to Agitation in Alzheimer’s Disease Is a Manifestation of Frontal Lobe Dysfunction (Q46521013):

Displaying 36 items.

• APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD). (Q30455082) (← links)
• Longitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer's disease (Q30587067) (← links)
• Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies (Q30988044) (← links)
• Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis (Q31138894) (← links)
• Group-Level Progressive Alterations in Brain Connectivity Patterns Revealed by Diffusion-Tensor Brain Networks across Severity Stages in Alzheimer's Disease (Q33881832) (← links)
• Agitation in dementia: relation to core cerebrospinal fluid biomarker levels (Q34250065) (← links)
• Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models (Q34418781) (← links)
• Incidence, Risk Factors and Consequences of Emergence Agitation in Adult Patients after Elective Craniotomy for Brain Tumor: A Prospective Cohort Study (Q34672134) (← links)
• Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition (Q34992886) (← links)
• Cerebral correlates of psychotic syndromes in neurodegenerative diseases (Q35194993) (← links)
• Genetic Deletion of the Clathrin Adaptor GGA3 Reduces Anxiety and Alters GABAergic Transmission (Q36021405) (← links)
• Neurologic and motor dysfunctions in APP transgenic mice (Q36347389) (← links)
• Factors Associated with Caregiver Burden in Dementia: 1-Year Follow-Up Study (Q36431138) (← links)
• Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer's disease receiving donepezil (Q36617998) (← links)
• Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II. (Q37007883) (← links)
• Vocally disruptive behavior in the elderly: a systematic review (Q37083750) (← links)
• Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease (Q37103064) (← links)
• Alternatives to atypical antipsychotics for the management of dementia-related agitation. (Q37151230) (← links)
• Behavioral and psychological symptoms of dementia: A study of symptomatology (Q37334227) (← links)
• Memory loss in Alzheimer's disease: implications for development of therapeutics (Q37352057) (← links)
• Neural basis of three dimensions of agitated behaviors in patients with Alzheimer disease (Q37601229) (← links)
• Management of behavioral problems in Alzheimer's disease (Q37680018) (← links)
• Behavioral and psychological symptoms of dementia and their management (Q37854476) (← links)
• A Conceptual Framework for Rejection of Care Behaviors: Review of Literature and Analysis of Role of Dementia Severity (Q37886368) (← links)
• Clinicopathological correlates of behavioral and psychological symptoms of dementia (Q37860194) (← links)
• Bipolar disorder: clinical perspectives and implications with cognitive dysfunction and dementia. (Q38017668) (← links)
• Post-traumatic stress disorder and prediction of aggression in persons with dementia (Q39106140) (← links)
• Drugs for Alzheimer's disease and related dementias (Q43010511) (← links)
• Relation between frontal lobe symptoms and dementia severity within and across diagnostic dementia categories. (Q44762259) (← links)
• Neuropsychiatric symptom clusters of Alzheimer's disease in Hong Kong Chinese: prevalence and confirmatory factor analysis of the Neuropsychiatric Inventory (Q44916698) (← links)
• Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model (Q47600911) (← links)
• Factors associated with increased caregivers' burden in several cognitive stages of Alzheimer's disease (Q48118523) (← links)
• Psychometric evaluation of a Spanish language version of the Screen for Caregiver Burden (SCB) in caregivers of patients with mixed, vascular and Alzheimer's dementia. (Q48303509) (← links)
• Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease. (Q50930340) (← links)
• The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables (Q50967806) (← links)
• Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer's Disease. (Q52951273) (← links)